The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The market is generally quite poor but atleast celadon has some interest. Really do think things are going to pop off here very soon. Think soon as this gets on the radar then its game on.
Could be the next market big thing this. Similar companies in the US are valued at billions. Celadon said they passed GMP registration for cannabis as an Active Pharmaceutical Ingredient. Meaning public supply could increase and more use as medical treatment. I suppose this shows real blue sky potential here.
Yea looks like this will be back over 100 this week
Glad I bought this last week.. this ascent might continue for a bit I'd say
Yeah, market cap of £56.18 million and the company seems to be actively engaged in research and development, looking at the trial targeting chronic pain treatment. If successful, this could significantly boost the company's revenue and market position in the future.
The acquisition of Vertigrow positions the company well for growth in the pharmaceutical sector. With recent approvals, the company's entry into cannabinoid therapy for chronic pain appears promising. This strategic move could attract investors seeking exposure to the burgeoning medicinal cannabis market. Investors should monitor regulatory developments closely.
Trial greenlit for cannabinoid therapy in chronic pain, a UK first, with approvals from NHS, MHRA, and Home Office. Great read titled “Celadon gets nod to start cannabis trial for pain in UK"
Really hoping this catches on soon!! Fingers crossed for a proper breakthrough soon!
Feeling optimistic about the potential here. just added a significant chunk to my portfolio
FUndraising going well with this one lately. Understandably going up now.
Https://x.com/celadonplc/status/1775080730462224670?s=48&t=w3jblJcIy9sSfgNuZfVU6Q
This hopefully will speed up the UK's transition to THCs
Took your advice and bought some yesterday, news coming by the looks, let’s hope the news is good..
Considering the positive trial consequences, fee-effectiveness, the future boom capability, and the CEO’s self-belief, this seems like the correct funding possibility. I suggest it even impacts the healthcare industry in a great way.
Seems promising. Could be a game-changer!
This hasn't aged well has it.
The CEO appears to be delivering on everything promised over the past couple of years. Another step forward with the economic analysis published today. Getting the NHS and private medical care sector on board should be transformative for the company. Still some way to go but definitely worth keeping an eye on this.
After reading this artical, I feel it's time to buy what you can afford, these shares will go through the roof!!
https://www.theguardian.com/society/2024/feb/11/wonder-drug-is-the-uk-ready-for-the-green-rush-of-medicinal-cannabis
Https://www.theguardian.com/society/2024/feb/11/wonder-drug-is-the-uk-ready-for-the-green-rush-of-medicinal-cannabis
CEL is emulating GW Pharma, they got bid for by a US Company 3 years ago at $7.2 billion
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second quarter of 2021.
Celeadon seem to be getting lots of positive recommendations as a good time to invest in this type of company, and the forecast for this type of medication is going to go through the roof, "Happy Days"
A hefty 35 k shares sold today in three tranches. Someone who had bought at 50.
Earlofaim.
Complete nonsense. DYOR fool, I say respectfully
HELD vs CEL
HELD - £5M Mcap,
196000 sqm facility,
Based in sunny Greece
Greece Bank funding in final stage
CEL
mcap £56m
100000 sqm facility
based in Midlands, Rainy, UK weather
£8k revenue
HELD can do 10 Bagger just to get even with CEL
GLA AND DYOR BEFORE ITS TOO LATE
Great interview - thanks for sharing.
110 - 115